Patient-reported outcomes and quality of life measures in atopic dermatitis.

[1]  I. Ackerman,et al.  Adult Measures of General Health and Health‐Related Quality of Life , 2020, Arthritis care & research.

[2]  J. Silverberg,et al.  Severity strata for five patient‐reported outcomes in adults with atopic dermatitis , 2018, The British journal of dermatology.

[3]  K. Schäkel,et al.  Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial , 2017, The Journal of allergy and clinical immunology.

[4]  C. Flohr,et al.  Measurement properties of quality‐of‐life measurement instruments for infants, children and adolescents with eczema: a systematic review , 2017, The British journal of dermatology.

[5]  H. Williams,et al.  Patient‐Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement , 2017, The British journal of dermatology.

[6]  M. Sculpher,et al.  Analyzing Health-Related Quality of Life Data to Estimate Parameters for Cost-Effectiveness Models: An Example Using Longitudinal EQ-5D Data from the SHIFT Randomized Controlled Trial , 2017, Advances in Therapy.

[7]  N. Devlin,et al.  EQ-5D and the EuroQol Group: Past, Present and Future , 2017, Applied Health Economics and Health Policy.

[8]  F. Tsai,et al.  Transformation of 5-D itch scale and numerical rating scale in chronic hemodialysis patients , 2017, BMC Nephrology.

[9]  C. Terwee,et al.  Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review , 2017, Allergy.

[10]  S. Ständer,et al.  Itch Assessment with Visual Analogue Scale and Numerical Rating Scale: Determination of Minimal Clinically Important Difference in Chronic Itch. , 2016, Acta dermato-venereologica.

[11]  P. Spuls,et al.  Reporting of symptoms in randomized controlled trials of atopic eczema treatments: a systematic review , 2016, The British journal of dermatology.

[12]  E. R. Sutherland,et al.  Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD). , 2016, Journal of the American Academy of Dermatology.

[13]  J. Silverberg,et al.  Research letter: Impact of pruritus on quality of life-A systematic review. , 2016, Journal of the American Academy of Dermatology.

[14]  H. Williams,et al.  Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative) , 2016, The British journal of dermatology.

[15]  C. Apfelbacher,et al.  Eczema Trials: Quality of Life Instruments Used and Their Relation to Patient-reported Outcomes. A Systematic Review. , 2016, Acta dermato-venereologica.

[16]  J. Schmitt,et al.  Measurement properties of adult quality‐of‐life measurement instruments for eczema: a systematic review , 2016, Allergy.

[17]  T. Bieber,et al.  Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults. , 2016, Journal of the American Academy of Dermatology.

[18]  M. Augustin,et al.  Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit , 2016, American Journal of Clinical Dermatology.

[19]  A. Finlay,et al.  Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16–17 years , 2016, The British journal of dermatology.

[20]  E. Adang,et al.  Cost-effectiveness of integrated care in frail elderly using the ICECAP-O and EQ-5D: does choice of instrument matter? , 2015, The European Journal of Health Economics.

[21]  S. Nutten.  Atopic Dermatitis: Global Epidemiology and Risk Factors , 2015, Annals of Nutrition and Metabolism.

[22]  J. Schmitt,et al.  Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME) , 2014, The British journal of dermatology.

[23]  M. Dimova,et al.  An Analysis of the Health Technology Assessment Recommendation and Guidance on Use of Eq-5d-5l in Cost-Effectiveness Modeling. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[24]  J. Stalder,et al.  Analysis of Correlations between Patient-Oriented SCORAD (PO-SCORAD) and Other Assessment Scores of Atopic Dermatitis Severity and Quality of Life , 2014, Dermatology.

[25]  J. Ring,et al.  Quality of health care of atopic eczema in Germany: results of the national health care study AtopicHealth , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[26]  S. Feldman,et al.  Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. , 2014, Journal of the American Academy of Dermatology.

[27]  J. Ravenscroft,et al.  Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods , 2013, The British journal of dermatology.

[28]  A. Finlay,et al.  Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995–2012 , 2013, The British journal of dermatology.

[29]  T. Nijsten,et al.  Measurement of health‐related quality of life in dermatological research and practice: outcome of the EADV Taskforce on Quality of Life , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[30]  A. Finlay,et al.  Infants' Dermatitis Quality of Life Index: a decade of experience of validation and clinical application , 2013, The British journal of dermatology.

[31]  R. Kobau,et al.  Monitoring population health for Healthy People 2020: evaluation of the NIH PROMIS® Global Health, CDC Healthy Days, and satisfaction with life instruments , 2013, Quality of Life Research.

[32]  A. Finlay,et al.  The Dermatitis Family Impact questionnaire: a review of its measurement properties and clinical application , 2013, The British journal of dermatology.

[33]  F. Gobbi,et al.  Italian validation of the Childhood Atopic Dermatitis Impact Scale: a contribution to its clinical application. , 2012, The Journal of investigative dermatology.

[34]  K. H. Kim,et al.  Quality of Life and Disease Severity Are Correlated in Patients with Atopic Dermatitis , 2012, Journal of Korean medical science.

[35]  S. Takeuchi,et al.  Visual analogue scale: evaluation of the instrument for the assessment of pruritus. , 2012, Acta dermato-venereologica.

[36]  Fleur Fritz,et al.  Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. , 2012, Acta dermato-venereologica.

[37]  H. Williams,et al.  Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting , 2012, Allergy.

[38]  K. Khan,et al.  SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions , 2012, Osteoporosis International.

[39]  T. Kawakami,et al.  Health‐related quality of life assessed by the effect of bepotastine besilate in patients with pruritus: Importance of emotions score in atopic dermatitis , 2012, The Journal of dermatology.

[40]  C. Prinsen,et al.  Interpretation of Skindex-29 scores: response to Sampogna and Abeni. , 2012, The Journal of investigative dermatology.

[41]  Suephy C. Chen,et al.  Clinical meaning in skin-specific quality of life instruments: a comparison of the Dermatology Life Quality Index and Skindex banding systems. , 2012, Dermatologic clinics.

[42]  T. Ruzicka,et al.  Climatotherapy at the Dead Sea: An Effective Treatment Modality for Atopic Dermatitis With Significant Positive Impact on Quality of Life , 2012, Dermatitis : contact, atopic, occupational, drug.

[43]  J. Marinković,et al.  Health‐related quality of life in patients with atopic dermatitis , 2012, The Journal of dermatology.

[44]  C. Prinsen,et al.  Interpretation of Skindex-29 scores: cutoffs for mild, moderate, and severe impairment of health-related quality of life. , 2011, Journal of Investigative Dermatology.

[45]  F. Sampogna,et al.  Interpretation of Skindex-29 scores. , 2011, The Journal of investigative dermatology.

[46]  T Reunala,et al.  Patient‐Oriented SCORAD (PO‐SCORAD): a new self‐assessment scale in atopic dermatitis validated in Europe , 2011, Allergy.

[47]  M. Boguniewicz,et al.  Atopic dermatitis: a disease of altered skin barrier and immune dysregulation , 2011, Immunological reviews.

[48]  A. Armstrong,et al.  Correction: Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985–2010 , 2011, PLoS ONE.

[49]  H. Williams,et al.  Harmonising Outcome Measures for Eczema (HOME).Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany , 2010, The British journal of dermatology.

[50]  Daniel J Buysse,et al.  The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. , 2010, Journal of clinical epidemiology.

[51]  M. Sprangers,et al.  Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors. , 2010, The Journal of investigative dermatology.

[52]  L. Hynan,et al.  The 5‐D itch scale: a new measure of pruritus , 2010, The British journal of dermatology.

[53]  C. Poole,et al.  Health‐related utility among adults with atopic dermatitis treated with 0·1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic® CONTROL study , 2009, The British journal of dermatology.

[54]  H. Williams,et al.  Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. , 2009, The Journal of allergy and clinical immunology.

[55]  R. Hays,et al.  Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items , 2009, Quality of Life Research.

[56]  C. L. Baeyer,et al.  Three new datasets supporting use of the Numerical Rating Scale (NRS-11) for children’s self-reports of pain intensity , 2009, PAIN®.

[57]  H. Maibach,et al.  Pruritus measurement and treatment , 2009, Clinical and experimental dermatology.

[58]  T. Holland-Letz,et al.  Medium‐dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study , 2009, The British journal of dermatology.

[59]  S. Barbarot,et al.  Patient-Oriented SCORAD: A Self-Assessment Score in Atopic Dermatitis , 2009, Dermatology.

[60]  T. Nijsten,et al.  Categorization of Skindex-29 Scores Using Mixture Analysis , 2008, Dermatology.

[61]  A. Finlay,et al.  The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results , 2008, The British journal of dermatology.

[62]  T. Pincus,et al.  Visual analog scales in formats other than a 10 centimeter horizontal line to assess pain and other clinical data. , 2008, The Journal of rheumatology.

[63]  Suephy C. Chen,et al.  A pilot quality-of-life instrument for pruritus. , 2008, Journal of the American Academy of Dermatology.

[64]  J. Sørensen,et al.  Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. , 2008, The Journal of rheumatology.

[65]  L. Doward,et al.  Quality of life of children with atopic dermatitis and their families , 2008, Current opinion in allergy and clinical immunology.

[66]  H. Williams,et al.  What are the best outcome measurements for atopic eczema? A systematic review. , 2007, The Journal of allergy and clinical immunology.

[67]  Jan Busschbach,et al.  Critical review of generic and dermatology-specific health-related quality of life instruments. , 2007, The Journal of investigative dermatology.

[68]  O. Chassany,et al.  Poor Reporting of Quality of Life Outcomes in Dermatology Randomized Controlled Clinical Trials , 2007, Dermatology.

[69]  M. Peters,et al.  Pain assessment in younger and older pain patients: psychometric properties and patient preference of five commonly used measures of pain intensity. , 2007, Pain medicine.

[70]  M. Chren,et al.  Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity, and responsiveness. , 2007, Archives of dermatology.

[71]  G. Lauzon,et al.  Itch Severity Scale: a self‐report instrument for the measurement of pruritus severity , 2007, The British journal of dermatology.

[72]  R. Grimalt,et al.  The Steroid-Sparing Effect of an Emollient Therapy in Infants with Atopic Dermatitis: A Randomized Controlled Study , 2006, Dermatology.

[73]  P. Beattie,et al.  An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants’ Dermatitis Quality of Life Index and Dermatitis Family Impact score , 2006, The British journal of dermatology.

[74]  P. Ng,et al.  CDLQI, Scorad and Ness: Are they Correlated? , 2006, Quality of Life Research.

[75]  P. Beattie,et al.  A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases , 2006, The British journal of dermatology.

[76]  M. Chren,et al.  Testing and reducing skindex-29 using Rasch analysis: Skindex-17. , 2006, The Journal of investigative dermatology.

[77]  S. Fukuhara,et al.  Cost-effectiveness of Liple (LipoPGE1) for arteriosclerosis obliterans patients in Japan: an economic evaluation using the EQ-5D instrument. , 2006, International angiology : a journal of the International Union of Angiology.

[78]  H. Wulf,et al.  Life quality assessment among patients with atopic eczema , 2006, The British journal of dermatology.

[79]  Y. Prost,et al.  Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel®, SDZ ASM 981): impact on quality of life and health‐related quality of life , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[80]  M. Chren,et al.  Development of the Childhood Atopic Dermatitis Impact Scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families. , 2005, The Journal of investigative dermatology.

[81]  A. Finlay,et al.  Translating the science of quality of life into practice: What do dermatology life quality index scores mean? , 2005, The Journal of investigative dermatology.

[82]  A. D. de Jong,et al.  Reliability and validity of the pain observation scale for young children and the visual analogue scale in children with burns. , 2005, Burns : journal of the International Society for Burn Injuries.

[83]  T. Kohlmann,et al.  International development of the Parents’ Index of Quality of Life in Atopic Dermatitis (PIQoL-AD) , 2005, Quality of Life Research.

[84]  M. Kawashima,et al.  Measurement of the Impact of Atopic Dermatitis on Patients' Quality of Life: A Cross‐Sectional and Longitudinal Questionnaire Study Using the Japanese Version of Skindex‐16 , 2004, The Journal of dermatology.

[85]  G. Jemec,et al.  Does visible atopic dermatitis affect quality of life more in women than in men? , 2004, Gender medicine.

[86]  H. Williams,et al.  The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. , 2004, Archives of dermatology.

[87]  M. Chren,et al.  Effects of Atopic Dermatitis on Young American Children and Their Families , 2004, Pediatrics.

[88]  L. Doward,et al.  Development of needs-based quality of life instruments. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[89]  Joy Adamson,et al.  'Questerviews': using questionnaires in qualitative interviews as a method of integrating qualitative and quantitative health services research , 2004, Journal of health services research & policy.

[90]  U. Gieler,et al.  German Adaptation of the Skindex-29 Questionnaire on Quality of Life in Dermatology: Validation and Clinical Results , 2004, Dermatology.

[91]  A. Finlay,et al.  10 years experience of the Dermatology Life Quality Index (DLQI). , 2004, The journal of investigative dermatology. Symposium proceedings.

[92]  Ross D Crosby,et al.  Defining clinically meaningful change in health-related quality of life. , 2003, Journal of clinical epidemiology.

[93]  D. Whalley,et al.  The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis. , 2002, Pediatrics.

[94]  M. Z. Norzila,et al.  Childhood atopic dermatitis: a measurement of quality of life and family impact. , 2002, The Medical journal of Malaysia.

[95]  R. Hay,et al.  Are quality of family life and disease severity related in childhood atopic dermatitis? , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[96]  M. Chren,et al.  Further Evidence of the Validity and Reliability of the Skindex-29: An Italian Study on 2,242 Dermatological Outpatients , 2002, Dermatology.

[97]  D. Revicki,et al.  Atopic dermatitis is associated with a decrement in health‐related quality of life , 2002, International journal of dermatology.

[98]  J. Brazier,et al.  The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.

[99]  E. Farmer,et al.  Use of the Dermatology Life Quality Index (DLQI) in a midwestern US urban clinic. , 2001, Journal of the American Academy of Dermatology.

[100]  A. Finlay.  Quality of life in atopic dermatitis. , 2001, Journal of the American Academy of Dermatology.

[101]  M. Chren,et al.  Measurement properties of skindex-16: A brief quality-of-life measure for patients with skin diseases , 2001, Journal of cutaneous medicine and surgery.

[102]  A. Finlay,et al.  The Infants’ Dermatitis Quality of Life Index , 2001, The British journal of dermatology.

[103]  R. Rabin,et al.  EQ-SD: a measure of health status from the EuroQol Group , 2001, Annals of medicine.

[104]  M. Johannesson,et al.  Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. , 2000, Acta dermato-venereologica.

[105]  Raj Jobanputra,et al.  The effect of skin diseases on quality of life in patients from different social and ethnic groups in Cape Town, South Africa , 2000, International journal of dermatology.

[106]  M. Testa,et al.  Interpretation of quality-of-life outcomes: issues that affect magnitude and meaning. , 2000, Medical care.

[107]  H. Wulf,et al.  Dermatology life quality index: data from Danish inpatients and outpatients. , 2000, Acta dermato-venereologica.

[108]  X. Badia,et al.  Measuring health‐related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI , 1999, The British journal of dermatology.

[109]  J. Ware,et al.  The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability. , 1999, Medical care.

[110]  A. Finlay.  Quality of life assessments in dermatology. , 1998, Seminars in cutaneous medicine and surgery.

[111]  P. Kind,et al.  Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). , 1998, British journal of rheumatology.

[112]  Jeffrey A. Johnson,et al.  Comparison of the EQ-5D and SF-12 in an adult US sample , 1998, Quality of Life Research.

[113]  Finlay,et al.  The family impact of childhood atopic dermatitis: the Dermatitis Family Impact questionnaire , 1998, The British journal of dermatology.

[114]  M. Chren,et al.  Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. , 1997, Archives of dermatology.

[115]  P. Kind,et al.  Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). , 1997, British journal of rheumatology.

[116]  N K Aaronson,et al.  An empirical comparison of four generic health status measures. The Nottingham Health Profile, the Medical Outcomes Study 36-item Short-Form Health Survey, the COOP/WONCA charts, and the EuroQol instrument. , 1997, Medical care.

[117]  J. Larson.  The MOS 36-Item Short form Health Survey , 1997, Evaluation & the health professions.

[118]  S J Zyzanski,et al.  Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. , 1996, The Journal of investigative dermatology.

[119]  R. Brooks.  EuroQol: the current state of play. , 1996, Health policy.

[120]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[121]  A Y Finlay,et al.  The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use , 1995, The British journal of dermatology.

[122]  C. H. Slater,et al.  Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation , 1994 .

[123]  A. Finlay,et al.  Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.

[124]  C. Sherbourne,et al.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. , 1994 .

[125]  N. Jones,et al.  Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire , 1993, Quality of Life Research.

[126]  A Coulter,et al.  Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. , 1993, BMJ.

[127]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[128]  S P McKenna,et al.  Measuring health status: a new tool for clinicians and epidemiologists. , 1985, The Journal of the Royal College of General Practitioners.

[129]  S P McKenna,et al.  The Nottingham Health Profile: subjective health status and medical consultations. , 1981, Social science & medicine. Part A, Medical sociology.

[130]  E M Backett,et al.  A quantitative approach to perceived health status: a validation study. , 1980, Journal of epidemiology and community health.

[131]  H. Williams,et al.  POEM a core instrument to measure symptoms in clinical trials : a HOME statement , 2016 .

[132]  H. Nakagawa,et al.  Comparative cut-off value setting of pruritus intensity in visual analogue scale and verbal rating scale. , 2015, Acta dermato-venereologica.

[133]  H. Williams,et al.  The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology. , 2015, The Journal of investigative dermatology.

[134]  Suephy C. Chen,et al.  ItchyQoL bands: pilot clinical interpretation of scores. , 2015, Acta dermato-venereologica.

[135]  Stephen Joel Coons,et al.  A Comparative Review of Generic Quality-of-Life Instruments , 2012, PharmacoEconomics.

[136]  D. Meads,et al.  Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis? , 2012, The Journal of investigative dermatology.

[137]  J. Q. Rosso,et al.  Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study , 2010 .

[138]  J. Q. Rosso,et al.  Patient-Oriented SCORAD: A Self-Assessment Score in Atopic Dermatitis. A Preliminary Feasibility Study , 2010 .

[139]  M. Grootenhuis,et al.  The Course of Life of Patients with Childhood Atopic Dermatitis , 2009, Pediatric dermatology.

[140]  Epidemiology and Health Services Research A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD) , 2004 .

[141]  R. Hay,et al.  Quality of life and disease severity are correlated in children with atopic dermatitis , 2004, The British journal of dermatology.

[142]  Epidemiology and Health Services Research The Children’s Dermatology Life Quality Index: validation of the cartoon version , 2003 .

[143]  J. Ware.  SF-36 health survey: Manual and interpretation guide , 2003 .

[144]  S. Mallinson,et al.  Listening to respondents: a qualitative assessment of the Short-Form 36 Health Status Questionnaire. , 2002, Social science & medicine.

[145]  T. S. Housman,et al.  Use of the Self‐Administered Eczema Area and Severity Index by parent caregivers: results of a validation study , 2002, The British journal of dermatology.

[146]  J. Ring,et al.  Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. , 1997, Dermatology.

[147]  M. Chren,et al.  Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. , 1997, The Journal of investigative dermatology.

[148]  A. Bowling.  Measuring Health. A review of quality of life measurement scales , 1997 .

[149]  Telemedicine diagnosis launched at Health Waikato. , 1995, New Zealand health & hospital.

[150]  A. Taïeb,et al.  Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. , 1993, Dermatology.

[151]  Julia Brasch,et al.  Severity Scoring of Atopic Dermatitis: The SCORAD Index , 1993 .

[152]  E. Nord.  EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway. , 1991, Health policy.

[153]  I. Wiklund.  The Nottingham Health Profile--a measure of health-related quality of life. , 1990, Scandinavian journal of primary health care. Supplement.

[154]  A. Kasuya.  EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[155]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[156]  P. Kind,et al.  The Nottingham Health Profile. , 1989, Social science & medicine.

[157]  M. Argyle,et al.  The Nottingham Health Profile: an analysis of its sensitivity in differentiating illness groups. , 1988, Social science & medicine.

[158]  P. Kind,et al.  The Nottingham health profile: a useful tool for epidemiologists? , 1987, Social science & medicine.